← Shelf·Three-peptide combination stack (BPC-157 + TB-500/TB-4 + GHK-Cu)·XXXII.
GLOW.
A vendor-formulated combination of three research peptides — BPC-157 (a synthetic pentadecapeptide), TB-500 (a 17-residue fragment of thymosin β-4), and GHK-Cu (the copper-tripeptide glycyl-histidyl-lysine). Sold in a single lyophilized vial at roughly a 5-to-1-to-1 mass ratio favoring GHK-Cu (approximately 52 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-4 per 70 mg vial, per the vendor's lot COAs). Each constituent has its own literature record; the combination itself is a marketing construct, not a published research protocol.
The stack itself is not endogenous — it is a laboratory-manufactured combination. Where each ingredient comes from is covered in its own entry: BPC-157 as a synthetic fragment of Body Protection Compound (a stomach-lining protein), TB-500 as the active fragment of thymosin β-4, GHK-Cu as a copper complex of a tripeptide sequence found naturally in human plasma and long documented in the cosmetic-chemistry literature.
Marketed as a triple regenerative stack — the sales pitch is that three constituent research-peptide profiles get combined into a single injectable and produce an integrated result. That framing has no published human trial data behind it in this specific ratio. The consumer marketing treats the sum as evidence-based when only the parts are individually documented, and each of those parts has its own well-documented gap between preclinical work and human trial evidence.
Straight talk
Straight talk: there is not a single published human clinical trial of BPC-157 + TB-500 + GHK-Cu as a combination in the ratios sold. Every claim you will read about the stack is either (a) an extrapolation from single-compound preclinical or cosmetic-chemistry work on one of the constituents or (b) anecdotal community reporting. The individual constituents' evidence bases are best inspected in each individual entry. Combining three research compounds does not add evidence to the case for any of them; it compounds the uncertainty threefold. Anyone selling this stack on the strength of GHK-Cu's cosmetic-ingredient record and asking you to accept that as evidence for the injectable triple stack is running well ahead of what any published study supports.
What the research studies
The literature, not a summary of it.
There is no literature on this specific combination. What exists is the literature on each constituent, which is best consulted in the individual entries. For a combination-level search — expect essentially zero hits at the human-trial level — read the research yourself:
Recommended vendor · Amino Club
≥ 99% by HPLC on the current lot — ILS Laboratories (ISO/IEC 17025).
$58.49 during Fall Sale (was $89.99)
35% off applied automatically at checkout when you land through this link.